Sulfur Metabolism and Sulfur-Containing Amino Acids: I- Molecular Effectors by Palego L. et al.
Volume 4 • Issue 7 • 1000158
Biochem Pharmacol
ISSN:2167-0501 BCPC, an open access journal 
Review Article Open Access
Biochemistry & Pharmacology: Open Access 
Palego, et al. Biochem Pharmacol (Los Angel) 2015, 4:1
http://dx.doi.org/10.4172/2167-0501.1000158
Abstract
The biology of the macro-element sulfur (S) is attracting an ever growing attention concerning cell physiology and 
human health. Sulfur metabolism works at the interplay between genetics and epigenetic as well as in the maintain 
of cell redox homeostasis. Indeed, unbalanced levels of S compounds in the body are actually under investigation as 
vulnerability factors and/or indicators of impaired cell oxidation state in a variety of human diseases. The purpose of this 
article is to overview some main S metabolic pathways in humans and their relevance in cell physiology and pathology. 
Since S is an essential nutrient for life, we first present its distribution and significance in the biosphere, focusing then 
on S metabolic fluxes which encompass S-containing amino acids (S-AAs), as well as sulfoconjugation, the synthesis 
and release of H2S together the formation of iron-sulfur cluster proteins. Despite the vastness of the topic, we would like 
to emphasize herein that the study of S networks in human pathology, especially in complex, multi-factorial disorders, 
deserves greater impulsion and deepening.
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Introduction
Among chemical element essential for life, the mineral sulfur 
(S) presents an unexpected complexity of bioactive derivatives that 
makes difficult to fully define its tissue distribution, metabolic fates 
and requirements for humans. A major input to deepen S biology 
and its impact on human health comes from results obtained 
in these last decades by the scientific community showing the 
relevance of S-containing biomolecules, as S-amino acids (S-AAs), 
reduced γ-L-Glutamyl-L-cysteinylglycine (glutathione, GSH) or 
3’-phosphoadenosine 5’-phosphosulfate (PAPS) in a variety of 
homeostatic processes in the body. Sulfur biomolecules exert important 
functions in all living organisms and their transformations are involved 
in metals’ transport, free radicals scavenging, tissue integrity protection, 
enzyme functionality, DNA methylation and repair, regulation of 
gene expression, protein synthesis, remodeling of extracellular matrix 
components, lipid metabolism and detoxification of xenobiotics/
signaling molecules in plants and animals [1,2]. If S biology is 
intricate, this area of investigation proves to be, at the same time, really 
fascinating: the widespread presence and diversity of organosulfur 
bioactive molecules in living organisms can be explained by the fact 
that this macro-element was one of the predominant atoms on Earth 
before life and the origin of life has been even attributed to S chemistry. 
It is indeed probable that former living organisms used S for energy 
metabolism and breathing under O2-free atmosphere conditions, a 
theory mirrored by the highly conserved S metabolism in bacteria as 
well as the evolutionary survival of species belonging to anion sulfide 
(S2-) producing bacteria as Archea. Moreover, the existence of “strict” 
anaerobic and sulfate (SO42-)-reducing Desulfovibrio species, which are 
able to grow under partial aerobiosis, attests the metabolic adaptation 
occurred during the first passage from a O2-free atmosphere to variably 
O2-enriched ecological niches [3]. The hypothesis of a common 
ancestor of plant or animal eukaryote cells deriving from the fusion 
of aerotolerant eubacteria and sulfidogenic Archea bacteria [4] could 
explain why most S chemical species play similar functions in plant and 
animal cells. The fact that the two Kingdoms express different S paths 
suggests instead that the coupling of oxidative reactions and S pathways 
for the maintain of chemical homeostasis could have contributed to the 
early divergence between plant and animal cells. Substantially, the study 
of S biochemistry provides further evidence to the hypothesis that cell 
evolution has been favored by mechanisms of interaction, exchange 
and transformation involving prokaryote and eukaryote genomes 
[5]. Hence, it follows that S species and S-containing biomolecules 
occupy a foremost position in metabolism, even from the evolutionary 
standpoint, an issue which deserves special attention for ecosystems 
and human health. Because of the complexity of S biochemistry, we 
have divided the review on S compounds and human health in two 
parts: the present, a first and more general section, which overviews 
some main S metabolism substrates, mentioning their involvement in 
human pathology, especially in complex, multi-factorial disorders; a 
second one which will deal with data obtained from the literature in 
clinical research showing S metabolism variation in specific complex 
diseases as autism spectrum disorders (ASD), schizophrenia and 
fibromyalgia, by outlining their significance and future perspectives. 
Sulfur in nature 
Sulfur is a non-metal element, the second of the oxygen (O)-headed 
VI group in the periodic table. Despite both O and S share many 
chemical properties and belong to the same group of elements, the S 
atom, because of its higher radius, is less electronegative and supplies to 
biomolecules a greater hydrophobic behavior than O.  Sulfur chemistry 
would thus reflect what introduced before: the ancient S metabolism has 
been preserved under aerobic conditions to restrain the consequences 
of oxidative metabolism and possible tissue damage by reactive oxygen 
byproducts [6]. On Earth, S occurs as a mixture of 4 stable isotopes, the 
most abundant being the 32S species (about 95%). It possesses oxidation 
states ranging from +6 (SO42-, oxyanion sulfate) to -2 (S2-, anion 
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sulfide).  Sulfur shows a mean concentration in the biosphere of about 
0.05%, being meanly concentrated in oceans where it reaches about the 
0.09%. The S biogeochemical cycle assimilates inorganic S species from 
the outer Earth crust into biomolecules of living organisms through a 
constant flux of S oxidization states [7]. Soil organic-S/SO42- species, 
reduced by sulfur-reducing bacteria to S2- (S dissimilatory reductions), 
as well as other S species and elementary S coming from volcanic 
and ocean sources, pass into the atmosphere and, after meteoric 
precipitations, into ground waters. Chemolithotrophic bacteria oxidize 
again them to SO42- by enzyme activities as sulfur oxygenase or sulfite 
oxidase. Sulfate, in turn, is absorbed by fungi and by plant roots 
through specific transporter proteins as SULTR [8], entering into the 
alimentary chain. Essentially, S is assumed by autotrophic organisms 
in the inorganic SO42- form, whereas heterotrophic organisms take S 
as both inorganic and organic S species. Sulfate is activated in all living 
organisms by a key enzyme which permits to assimilate the anion into 
cell metabolism: ATP sulfurylase. This enzyme integrates the mineral S 
in the biochemical machinery of cells from all living organisms, giving 
then origin to divergent pathways in plant or animal cells [9,10]. The 
reaction mediated by ATP sulfurylase consists in the formation of 
adenosine-5’-phosphosulfate (APS) by transferring SO42- to ATP and 
liberating pyrophosphate (PPi). The product of this reaction, APS is 
thus the activated form of SO42- [11]. In plants, S metabolism starts with 
soil SO42- assimilatory reduction pathways forming organic species, 
firstly the S-AA Cysteine (Cys), which then produces Methionine 
(Met) and all other bioorganic S derivatives. The reaction catalyzed by 
the enzyme ATP-sulfurylase represents the first step of Cys formation 
from SO42- in plant cells, through the precursor APS. In plants, two 
other enzymes, APS-reductase, a flavoprotein, and sulfite-reductase 
are able to produce a SH-  group which is transferred to O-acetylserine 
generating Cys [1,7]. These metabolic reactions make plants the 
primary producers of organic S compounds in the alimentary chain. In 
the animal Kingdom, S as SO42- and/or S-containing biomolecules are 
introduced with beverages and food undergoing several metabolic fates, 
such as, for instance, Met transmethylation and the Cys-producing 
reactions of transsulfuration [2]. The requirement of S-compounds is 
thus provided by the diet, and, for that, S content is among the most 
abundant macro-elements in animal tissues, just after C,H, O, N, Ca 
and P [7]. Despite this, Met tissue amounts can be critical owing to the 
AA use in a variety of fundamental reactions. Indeed, Met is utilized to 
form S-adenosyl-methionine (SAM), the main methyl donor substrate, 
and Cys via the intermediates Homocysteine (HCys) and Cystathionine 
(Cyst). Cysteine subsequently promotes Taurine (Tau), GSH, H2S 
or SO42- formation. Figure 1 depicts the chemical structures of some 
among the main substrates of human S metabolism, S-containing AAs, 
some of their derivatives at two or three AAs, as well as S-adenosyl 
compounds.
Sulfur amino acids and their derivatives in humans
As afore mentioned, in humans, S inorganic species as SO42- and 
S-biomolecules, including S-containing AAs, their derivatives, 
S-vitamins as biotin or S-coenzymes and cofactors as coenzyme A and 
α-lipoid acid are obtained from a normal and equilibrated diet. As 
concerns S-AAs, Met and Cys are proteinogenic S-AAs, whereas HCys 
and Tau are not contained in proteins. Once introduced with diet, 
S-AAs enter in cell metabolic paths interlaced with several homeostatic 
processes in which Met and Cys exert the role of the main players. In 
the light of all reactions and processes which entail Met, this AA is 
probably the essential one which influences the greatest number of 
physiological processes. For this reason, cells are able to recover and 
maintain diet Met, to avoid its loss. As an example, among other 
metabolic uses, it is worth mentioning that considerable Met amounts 
are recruited for mRNA translation: Met is the initiating AA in the 
synthesis of eukaryotic proteins, while formyl-Met plays the same role 
in prokaryotes. In addition, Met maintains cell Cys reserve promoting 
its formation and for that Cys is considered a semi-essential AA which 
in turn origins many other fundamental S paths. The fact that Met and 
Cys are both protein AAs implies that their tissue pool is alimented not 
only by diet but also by hormone-regulated protein turn-over and 
degradation, as for all other protein AAs. As components of proteins, 
both Met and Cys are primary intermediates for spatial conformation, 
assembly and structure stability of peptides and polypeptide chains, 
regulating their folding features and functionality. Methionine is a 
thioether compound, a hydrophobic AA involved in interactions 
within and between proteins and peptides: protein domains rich in Met 
residues have been identified in active sites of proteins implicated in 
transport, trafficking or enzymes to prevent oxidation [6,12]. The AA 
Cys is a thiol, which contains the nucleophilic group –SH able to form 
S-S bridges. For instance, S-S bridges regulate protein shape and are 
highly contained in proteins linked to defense against bacteria and 
viruses (e.g., immunoglobulins and T-cell receptor) or to transport and 
structural function (e.g., metallothioneins, ferredoxin or keratin); 
additionally, S-S bridges occupy relevant positions in the catalytic site 
of several enzymes to yield their active conformations. Extracellular 
proteins present a higher Cys content vs. intracellular ones (ratio of 
about 2:1) [13], implying a main role of Cys in connective tissues. 
Cysteine also contributes to 3D spatial conformation and shape of 
peptides: the nonapeptides oxytocin and vasopressin, modulators of 
social behavior in mammalians, contain in their AA sequences two Cys 
residues bonded through a disulfide bridge. Figure 2 schematically 
presents the main reactions of Met metabolism in humans, divided 
into: transmethylation, remethylation, originating the so called “Met 
cycle”, and the irreversible Cys formation step of the transsulfuration 
pathway. The Met cycle starts from dietary or protein degradation Met, 
and then it continues with S-adenosyl-Met (SAM) and HCys formation 
(transmethylation) or comes back to Met by HCys remethylation [14]. 
Through irreversible transsulfuration reactions, Met can be instead 
transformed into Cys, giving origin to Cys metabolism as GSH or Tau 
formation. The pivotal intermediate of these two Met destinies is HCys. 
Thus, Met/HCys homeostasis depends upon the subtle balance between 
three metabolic fluxes: 1) transmethylation to HCys, 2) HCys 
remethylation to Met (Met cycle), and 3) transsulfuration of HCys to 
Cys. Methionine, by transmethylation reactions, is the precursor of 
SAM, the most studied methyl donor substrate in cells which acts in 
key, SAM-sensitive methyltransferase reactions involving a variety of 
acceptors and co-substrates, participating, for instance, to the 
formation of neurotransmitters, the pineal hormone melatonin (MLT), 
methylglycine, as well as to the processes of methylation of DNA 
(cytosine adjacent to guanosine residues, CpG sites), histones and 
phospholipids [15-17]. For this last function, SAM plays main actions 
in DNA replication and repair whereas its derivative S-adenosyl-HCys 
(SAH) promotes a powerful negative feed-back on methyltransferase 
activities [6], favoring HCys remethylation to Met. In more detail, 
SAM is formed from Met and ATP by Met adenosyltransferase; then, 
SAM loses a methyl group by a x-co-substrate methyltransferase 
producing SAH which is, in turn, converted into HCys by the enzyme 
S-Adenosyl hydrolase (Figure 2, 1-3). Production of HCys can generate 
transsulfuration reactions to Cys or remethylation to Met through the 
intersection with folate metabolism or the choline-betaine 
(trimethylglycine) way (Figure 2- 3,4). Transsulfuration reactions are 
irreversible steps so that HCys is not converted again to Met. 
Transsulfuration involves the activity of Cystathionine β-synthase 
Citation: Palego L, Betti L, Giannaccini G (2015) Sulfur Metabolism and Sulfur-Containing Amino Acids: I- Molecular Effectors. Biochem Pharmacol 
(Los Angel) 3: 158. doi:10.4172/2167-0501.1000158
Page 3 of 8
Volume 4 • Issue 7 • 1000158Biochem Pharmacol (Los Angel)ISSN:2167-0501 BCPC, an open access journal 
(CBS) which leads to Cyst formation from HCys and subsequent 
Cystathionine-γ-liase (CGL) action which transforms Cyst in Cys by 
the release of α-ketobutyrate and ammonia (Figure 2-8,9). The synthesis 
of Cys by transsulfuration can produce other S-containing substances 
as the intra-cell free radical scavenger GSH, synthesized from the 3 
AAs glycine, glutamate and Cys, and the non-protein AA taurine 
(Tau). In summary, S-biomolecules can increase in tissues and 
bloodstream from their absorption, from the diet or protein degradation 
(Met and Cys) under hormonal control but their constant levels are 
guaranteed by the biochemical S “fuel” represented by the Met cycle 
and transsulfuration, as verified through studies using in vivo Met 
tracers [18]. The Met cycle is regulated by the gene expression of 
enzymes: a tissue-specific gene expression/regulation occur. For 
instance, liver shows the highest expression of Met cycle enzymes, but 
these last or their isoforms can be also highly expressed in pancreas, 
kidneys, brain, skeletal muscle and heart [14,19,20]. Transsulfuration 
enzymes are all equally expressed only in few tissues [20]; in the human 
brain, a relatively higher CBS/CGL ratio is observed indicating that 
HCys is prevalently transformed into Cyst in this tissue; in the human 
kidney and cardiovascular system, a lower CBS/CGL ratio is present 
and HCys remethylation to Met is predominant [20]. This would imply 
that Cys production undergoes a regulation on the basis of tissue-
specific redox necessities. Moreover, the tissue-dependent gene 
expression of different enzyme isoforms of the Met cycle changes with 
age and gender; for instance, HCys remethylation is greater in males 
than females on normal diet. Hormones as insulin, glucagone or 
thyroxine orchestrate Met metabolism balance by regulating enzyme 
expression and activities [21]. After feeding, insulin allows AAs uptake 
inside cells for protein synthesis, while favoring Met remethylation; 
glucagon decreases Met levels in the bloodstream while increasing 
transmethylation and transsulfuration enzyme activities which bring to 
Cys synthesis to provide reserves of GSH, Tau or other Cys derivatives 
which can exert their scavenger and anti-oxidant activities during the 
fasting period. Also, thyroxine promotes SAM formation and HCys 
transformation into Cys; this explains why unbalanced HCys 
metabolism is linked to diabetes and hypothyroidism [21]. A pivotal 
regulation of the Met cycle is given by SAM itself. The role of SAM 
consists in positive allosteric feedback activation: SAM production in 
transmethylation path enhances the whole process. The liver is the only 
district which expresses MAT-I, a high Km Met adenosyltransferase 
isoform which subtracts the excess of dietary Met [14]. Elevated SAM 
promotes Met oxidation by transsulfuration, inhibits HCys 
remethylation to Met, bringing the cycle towards Cys synthesis [6]. A 
reduced Met availability to transmethylation and transsulfuration is 
obtained by Met oxidation and conversion to Met sulfone, which is 
reversed to Met through the action of Met sulfone reductases (MsrAs), 
Figure 1: The chemical structures of some among the main sulfur-containing biomolecules active in human metabolism. Apart from their grouping in A), B) and 
C), Met and Cyst are thioether S derivatives; Cys, HCys and GSH are thiols; Cystine carries a disulphur bond.
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a family of enzymes which decrease with aging and neurodegenerative 
processes [22]   (Figure 2,26). As afore mentioned, also Cys follows a 
variety of fates, comprising incorporation into protein, Tau or GSH 
production and oxidation to SO42-. High protein diet stimulates both 
transmethylation and transsulfuration enzyme activities, increasing 
endogenous production of HCys and Cys [23]. The contribute of Cys 
synthesis from HCys transsulfuration is important, even in the presence 
of dietary Cys: this is mainly due to the important amount of Cys 
consumed for generating GSH, Tau and other cofactors and 
biomolecules. Reactive oxygen species (ROS) and peroxide species, 
formed under stress-related conditions, promote transsulfuration, 
while the antioxidant ones reduce it: this indicates that in the presence 
of oxidant species, transsulfuration provides Cys for GSH request, 
while increased antioxidants slow down Cys synthesis, less demanded 
for GSH synthesis. Thus, stress, ROS formation and apoptosis signals 
can be counterbalanced by pro-oxidant activities, whose efficiency and 
availability is critical for cell health. For GSH synthesis, Cys enters 
together glutamate into the γ-glutamyl cycle (Figure 2-18,19) forming 
the dipeptide γ-glutamyl-L-cysteine by γ-glutamyl-L-cysteine 
synthetase; Gly is then added to the dipeptide by glutathione synthetase. 
This tripeptide, more concentrated inside cells rather than body fluids, 
represents a storage form of Cys and its disulfide derivative Cystine. 
The structural GSH feature is the γ-glutamyl linkage, which facilitates 
its role in a remarkable variety of reactions and functions such as 
protection of sulfidryl groups of coenzyme A, other cofactors, proteins 
and enzymes. In addition to being one of the major protective molecules 
for hepatocytes, GSH exerts multiple roles in all cells, as presented in 
the next paragraph. Next to GSH, another product of Cys metabolism 
is Tau, a sulfonated β-amino acid (2-aminoethanesulfonic acid). This 
non protein S-AA is synthesized in the animal Kingdom and results 
from the activity of Cys dioxygenase to produce the intermediate 
cysteine sulfuric acid (3-sulfinoalanine), which is then decarboxylated 
by sulfino-alanine decarboxylase into hypotaurine. Hypotaurine is 
then oxidized to Tau [23] (Figure 2, 10-12)  
Taurine has been found highly concentrated in animal and human 
cells, especially in excitable tissues as brain, retina, muscle and hearth; 
it is also present in the liver and kidney, while it’s circulating levels 
being, in comparison, much lower.  Taurine function has been coupled 
to antioxidant activities, osmoregulation and modulation of Ca2+ levels 
[24]. In the CNS, where Tau is highly concentrated, this β-AA acts as a 
neuromodulator and neuroprotector, also preserving the homeostasis 
of retinal functions. Taurine plays a role also in bile salts formation. 
Nevertheless, the full comprehension of its tissue distribution and 
tissue-specific physiological role deserves additional investigation. 
Taurine, by its chemical structure, is supposed to stabilize membranes 
interacting with phospholipids, contributing to their fluidity and 
excitability. Taurine physiology has been linked to the classical 
neurotransmitter γ-aminobutyric acid (GABA): Tau can mimic some 
effects provoked by GABA release, including the interaction with the 
GABAA Cl- ionophore receptor [25].
Also coenzymes and vitamins contribute at upholding Met 
metabolism homeostasis. First of all, the vitamin folic acid and its 
derivative tetrahydrofolate (THF) which generates the so called “one 
C metabolism” and HCys remethylation to Met (Figure 2- 4,5). Folic 
acid is synthesized by dihydrofolate reductase requiring NADPH. 
Glycine and Ser inter-conversion produces THF and 5,10 methenyl-
THF, this last deriving from Gly decarboxylation. Vitamin B-12 is 
required for Met synthase function and FAD is the prosthetic group 
of Methylenetetrahydrofolate Reductase (MTHFR). Impaired activities 
of reductases and transulfuration enzymes CBS and CGL have been 
observed in case of loss of vitamin B-6 (pyridoxal phosphate) necessary 
for their catalytic function. This explains why deficiency in one of these 
vitamins, cofactors and groups provokes high HCys circulating levels 
[6,26]. Finally, it should be pointed out that, beside gender and aging, 
the different development stages can affect the activity of enzymes 
participating to the Met cycle [27]. Even if we do not treat this topic, 
the interaction between Met, Cys and selenium (Se) species coming 
from diet or intracellular metabolism, represents another big chapter 
in S biology: seleno-Met leads to the formation of selenide species, 
the co-substrate of the enzyme seleno-Cys synthase (Figure 2- 27), an 
enzyme able to transform Ser-tRNA into seleno-Cys-tRNA, this last 
incorporated into selenoproteins. The Se-S species and selenoproteins 
possess a strong antioxidant activity in the body, especially the 
compound seleno-Cys [28]. Figure 2 (23,28)  also refers to other paths 
linked to Cys, as CoA formation or iron-sulfur cluster biogenesis and 
synthesis of metallothioneins, small Cys-rich proteins, which also plays 
a fundamental action in the metabolic anti-oxidant defense machinery 
against oxidative stress and metal/heavy metal toxicity. 
The reduced and oxidized glutathione system
The GSH anti-oxidant system deserves a separate paragraph. 
Glutathione is in fact the most abundant thiol compound in cells 
and its function is critical for the maintain of the cell redox status. 
Moreover, this compound binds to xenobiotics and several endogenous 
compounds for detoxification purposes [29]. Several reviews, as 
the paper of Wu and coauthors [30], exhaustively describe the GSH 
relevance in cell physiology. In particular, once formed from Cys in 
tissues and cells, GSH fates are multiple: it can exert “per se” a feed-
back regulation on its own synthesis and, concomitantly, it undergoes 
homeostatic redox reactions involving the activities of two main 
enzymes, glutathione peroxidase and glutathione reductase (Figure 
2,20,21). These two enzymes are part of the cell anti-oxidant defenses 
constituting the GSH-Px/GSSG-Rd system which maintains the suitable 
redox state of cells and tissues [31]. The selenoenzyme Glutathione 
peroxidase transforms GSH into GSSG (glutathione disulfide or 
oxidized form) to counteract hydroxyperoxides’ formation avoiding 
cell damage [32]. Several isoforms of GSH peroxidase are expressed, 
each capable to counteract the generation of diverse hydroxyperoxide 
chemical species. Glutathione disulfide is transformed back to GSH by 
the GSSG reductase enzyme activity, a NADPH-dependent activity, as 
in thioredoxin system [33]. The extra/intracell levels of GSH are also 
regulated by the enzyme gamma-glutamyl transpeptidases (γ-GT, 
Figure 2, 22) in cells and tissues expressing this activity: γ-GT is able to 
break down the tripeptide originating again Cys interacting with AA 
metabolism. This enzyme is acquiring further interest in human health 
since it is able to maintain the homeostasis of both GSH or Cys and can 
regulate cell proliferation/apoptosis [34,35].
Sulfoconjugation and detoxifying function 
This paragraph presents the relationships between S, S 
biotransformations and detoxification processes. The metabolic 
inactivation of endogenous signals and xenobiotics represents a pivotal 
step of cell response regulation, avoiding their noxious accumulation 
in the adult body and during development. Inactivation is mediated 
by phases I and II detoxifying enzymes, which promote, as the final 
passage, the excretion in urines of bioactive compounds transformed 
into water-soluble derivatives. One of these activities is sulfo-
conjugation or sulfation, mediated by the families of sulfotransferases 
(STs) [36]. Sulfotransferases, in the presence of the S compound 
PAPS as the co-substrate and sulfate donor, inactivate a variety 
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of bioactive compounds. These last include drugs, hormones, and 
neurotransmitters as catecholamines or end products of catabolism 
producing hydrophilic sulfo-derivatives excreted in urines. Sulfation 
is an essential cell reaction implicated also in other processes as the 
remodeling of glycosaminoglycans, polysaccharide components of 
the extracellular matrix and proteoglycans, implying a main role in 
structural function and formation of connective tissues. Sulfation 
and ST activity also participate to post-translational modifications of 
tyrosine residues in secretory proteins [37]. The S molecule PAPS is 
produced by 2 ATP molecules, SO42- and the activity of two enzymes, 
ATP sulfurylase and APS-kinase (Figure 2 – 15, 16). Bifunctional forms 
of ATP sulfurylase/APS-kinase have been also identified in humans. 
Anyway, in substance, ATP and SO42- availability significantly affect 
the sulfation capacity of STs.  Diet and water are the main sources 
of SO42-. After assumption with diet, both intestinal absorption and 
renal re-absorption of SO42- contribute to maintain the homeostasis of 
the body amount of this anion as well as its availability to STs action 
[38]. Sulfate can be generated also by Cys after its transformation 
into Cys sulfinate by Cys dioxigenase, an enzyme in common with 
the Tau synthesis path, subsequent formation of sulfinylpyruvate by 
cyteinsulfinate transaminase, release of sulfite and oxidation to  SO42- 
through  the action of a sulfite oxidase (Figure 2 - 10,13,14] [38].  As 
a consequence, increased amounts of Met and Cys can raise SO42- 
levels. Other enzyme activities which boost the SO42- intracellular pool 
are lysosomial sulfatases involved in cell turn-over, whose activity 
leads to macromolecule degradation [38]. Sulfotransferases forms a 
heterogeneous class of enzymes: actually, 5 families of STs have been 
identified and each can recognize a specific group of substances. These 
families are also differentially expressed in anatomical districts and 
brain. It has been suggested that brain STs play a crucial role in the CNS 
development. Research on ST families is an open field and the most 
studied ST1 one is actually divided into 5 subtypes [36,38]. The ST1A 
is highly expressed in brain, platelets, liver, breast and gastrointestinal 
tract. Its preferential substrates are catecholamines or phenols and 
can be also distinguished in thermo-stable or thermo-sensitive forms 
[39]. The ST1B family produces sulfation of thyroid hormones whereas 
ST1C overall recognizes xenobiotic compounds and ST1E promotes 
the sulfoconjugation of estrogens. The ST2 family targets cholesterol, 
pregnenolone, DHEA and neurosteroids. Intriguingly, there is also 
evidence that STs contributes to fetal development and mother-fetus 
exchanges through sulfate transporter molecules [40,41]. In our lab, we 
have previously demonstrated that platelet ST shows seasonal rhythms 
[42], depending on gender [43], underlining that cells can adapt 
detoxifying activities or neurotransmitter signaling to photoperiod 
Figure 2:  Main pathways of sulfur metabolism in humans. Enzymes of Met transmethylation and remethylation: 1- Met adenosyl transferase; 2- x-methyl transferases; 
3- S-adenosyl-HCys hydrolase; 4- betaine:HCys methyltransferase; 5-Met synthase; 6-Serine hydroxymethyl transferase; 7-methylenetetrahydrofolate reductase 
(MTHFR). Enzymes of Met transsulfuration: 8- Cystathionine β-synthase; 9- Cystathionine γ-lyase. Enzymes of Tau synthesis: 10-Cys dioxygenase; 11-sulfino-
alanine decarboxylase; 12- HypoTau oxidase. Enzymes of sulfate formation: 10- Cys dioxygenase; 13- cyteinsulfinate transaminase; 14- sulfite oxidase. Enzymes 
of PAPS formation: 15- ATP sulfurylase; 16- APS-kinase. Sulfoconjugation: 17- sulfotransferase family. Enzymes of GSH formation: 18- γ-glutamyl-L-cysteine 
synthetase; 19- GSH synthetase. Enzymes of the GSH-GSSG system: 20- GSH peroxidase; 21-GSSG reductase. Enzymes of GSH catabolism: 22- γ-glutamyl- 
transpeptidase (γ-GT). “Iron-sulfur” cluster biogenesis: 23- Cys desulfurase. Enzymes of H2S formation: 8- Cystathionine β-synthase; 9- Cystathionine γ-lyase; 24- 
Cys aminotransferase; 25- 3-mercaptopyruvate sulfurtransferase. Met sulfone reductases: 26- the MsrA family. CoA synthesis: 27- phosphopantothenoylcysteine 
synthetase. Selenoproteins: 28- SelenoCys Synthase. 
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as well as to the different necessities during the lifespan in men and 
women separately.  
Hydrogen sulfide as a gasotransmitter in humans 
A promising new interest concerning investigation on the biology 
of S chemical species in mammalians and humans relates to the 
preserved capacity of eukaryotic cells at producing the sulfide acid H2S, 
the final product of dissimilatory reactions in SO42--reducing bacteria. 
In particular, H2S, considered highly toxic, a poisonous gas with a 
typical odor of rotten eggs, is now classified among the endogenously 
produced gasotransmitters involved in many cell homeostatic 
processes as nitric oxide (NO) and carbon monoxide (CO), each 
other interacting [44,45]. This acidic molecule, is present in cells as 
HS- or as a persulfide bound form in proteins, and is an example of 
the relative concept of toxic, noxious compounds for life functions. 
H2S body levels are maintained very low by pO2 which enhances its 
clearance into thiosulfate and sulfate. Enzymes implicated in H2S 
formation are the transsulfuration enzymes CBS and CGL, which 
catalyze Cyst and Cys formation from HCys. The first produces serine, 
H2S, pyruvate and ammonia starting from Cys, the second induces Cys 
dimerization to Cystine, forms thiocysteine and its rupture to H2S. 
The enzyme CGL has been found to catalyze H2S formation through 
several pathways [46] (Figure 2- 8,9]. CGL can produce Cyst and H2S 
starting from Cys and HCys. A third minor synthesis pathway is H2S 
formation by 3-mercaptopyruvate sulfur transferase (3MST) and Cys 
aminotransferase using Cys and α-ketoglutarate as the substrates [44-
47]. These 2 enzymes are expressed both in the brain and periphery 
(Figure 2 – 24, 25). As aforementioned, CBS and CGL are differentially 
regulated in the body, thus CGS produce H2S overall in the CNS, while 
CGL forms it in peripheral districts, cardiovascular system and smooth 
muscle cells. Among the main homeostatic roles played by H2S in cells, 
there are cardiovascular functions, respiration and muscle relaxation; 
moreover, H2S release has been implicated in the regulation of blood 
pressure through the opening of ATP-dependent K+ or voltage-gated 
channels of vascular tissues producing a vasorelaxant action [48-
51]. Other H2S roles include apoptosis regulation, acting as a kind 
of metabolic “sensor” to prevent tissue damage and to counteract 
inflammation [52]. More, as most S chemical species in the body, 
H2S promotes scavenging of ROS. The discovery of H2S endogenous 
production has paved the way towards the comprehension of its 
regulation in human disease: defective H2S production has been related 
to arterosclerosis and impairment of the cardiovascular function 
[45,52]. H2S production is inhibited by the other two gasotransmitters 
via CBS inactivation. Insulin and glucocorticoids regulate CBS/CGL 
and can exert opposite effects, inhibitory or stimulatory, respectively, 
on H2S release. Interestingly, some authors have even observed a sex 
hormone modulation of the gasotransmitter release [53]. Another 
district where H2S acts as a modulator is the gut, where the gas is also 
produced by S-metabolizing microbiome strains [54], Gram-negative 
species or aerotolerant Proteobacteria [55]. In the brain, H2S has been 
linked to hippocampal long-term potentiation, to the negative feed-
back of glucocorticoids release and neuroprotection [56].  
Iron-Sulfur cluster proteins and human metabolism
Another key section of S biology embraces iron-sulfur (Fe-S) cluster 
proteins and their regulatory action at the level of the respiratory chain 
and mitochondrial function. Iron-sulfur clusters are prosthetic groups 
contained in metalloproteins, as NADH dehydrogenase, xantine 
deydrogenase, coenzyme Q reductases, Krebs cycle enzymes (aconitase 
and succinate dehydrogenase), flavoproteins and ferredoxins involved 
in the mitochondrial respiratory chain, proteins of DNA metabolism 
and repair or iron-regulatory proteins as IRP1 [57]. Among these 
clusters there are the [2Fe-2S] or the [4Fe-4S] forms, composed by 
tetrahedral iron atoms bounded to S and to proteins through sulfidryl 
-SH Cys groups. The biogenesis of these Fe-S groups in mammalians 
cells has been elucidated and consists in a series of reactions concerning 
the enzyme Cys desulfurase (NFS1) [57] (Figure 2, 23). In mammalians, 
these reactions start with the formation of a protein complex including 
the enzyme NFS1 and a bound scaffold protein (ISCU). Once again, 
this S pathway, precisely a Cys pathway, needs vitamin B6 pyridoxal 
phosphate as the cofactor together an additional monomeric protein, 
the ISD11. The complex transforms 2 molecules of Cys into 2 molecules 
of Alanine (Ala) in the presence of iron (2 Fe2+). The frataxin protein, 
together a ferredoxin e- donor, also participates to the enzyme complex 
formation and the first steps of “iron-sulfur” cluster biogenesis. Once 
formed, Fe-S clusters are transferred to specific recipient proteins, 
providing to these ones a versatile capacity to accept or donate electrons 
depending on redox potential, oxidation state and conformational 
changes. The Fe-S clusters are highly conserved in bacteria, yeasts, 
plants, animals and high vertebrates. First living organisms may 
have used early formed Fe-S clusters to capture and release electrons 
under primeval conditions. The importance of Fe-S clusters has been 
evidenced by molecular biology studies and genetic defects of Fe-S 
cluster containing proteins. A variety of inherited mutations of genes 
codifying for these proteins has been identified: these mutations are 
linked to a wide spectrum of severe human diseases, encompassing 
the neurodegenerative disease Friedreich ataxia, a sideroblastic 
anemia and a form of myopathy which derives from mutations of 
the Fe-S cluster assembly scaffold factor ISCU [58]. The research on 
proteins containing these prosthetic groups is relatively recent and, 
for this reason, represents an open field of investigation [59]; it is thus 
conceivable to think that other human diseases and mitochondrial 
malfunctions could be related to an altered expression/regulation of 
this group of proteins within tissues. 
Sulfur biology and human disease
From such considerations, it comes out that S biotransformations 
entail much awareness for human pathology. Sulfur metabolism is 
the heart of a variety of basic homeostasis functions inside cells and 
tissues. Sulfur compounds play a protective role during immune 
response [60] and in a variety of other cell responses [61]. The fact 
that genetic Mendelian defects at the levels of the Met cycle and 
transsulfuration enzymes lead to relevant syndromes and disorders 
linked to hypermethionemia, homocystinuria or cystathioninuria 
further underlines the importance of S metabolism in the body [14]. 
On the other hand, changes in S compounds’ formation and catabolism 
have been reported as significant metabolic indexes in complex diseases 
with a multifactorial and multifaceted pathogenesis. Polymorphisms 
or unbalanced S metabolism and S-AAs levels have been revealed in 
cardiovascular diseases, musculoskeletal disturbances, diabetes and 
neurodegenerative disorders as Alzheimer disease [62-67]. Moreover, 
S metabolism investigation needs to be deepened in the field of clinical 
research on complex diseases and overlapping conditions as obesity, 
neuropsychiatry and pain perception disorders, all at unclear etiology 
[68]: the second section of this review will specifically deal with the 
involvement of S metabolism in some specific human complex 
disorders and the possible use of valuable instruments to apprise the 
levels of S intermediates as useful parameters in this clinical research 
field. 
Conclusion
The chief role of S metabolism in cells and its tight coupling to 
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oxidative stress suggest the involvement of S compounds in basic 
functions as the homeostasis of chemical cell composition as well as 
in defense and detoxifying mechanisms. Sulfur inorganic/organic 
compounds work as main metabolic sensors in the modulation of 
environment-cell interplays. The development of S biology studies 
can pave the way toward new research fields in human disease and, 
potentially, in pharmacology. For instance, a better evaluation of the 
mechanisms of regulation, gene expression of involved enzymes in 
specific tissues during the lifespan, the formation and use of SO42-/H2S 
within cells is prospected together the investigation of S organic species 
which interact with metals/semi-metal in Fe-S clusters or Se-S species 
and their regulation, or the assessment of epigenetic DNA/protein 
SAM-dependent methylation patterns and the activity of the GSH/
GSSG system.
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